Spa Essetifin's Net Worth
$6.84 Million
Who is Spa Essetifin?
Spa Essetifin has an estimated net worth of $6.84 Million. This is based on reported shares across multiple companies, which include FENNEC PHARMACEUTICALS INC., DOR BIOPHARMA INC, SCICLONE PHARMACEUTICALS INC, QUESTCOR PHARMACEUTICALS INC, and REGENERX BIOPHARMACEUTICALS INC.
SEC CIK
Spa Essetifin's CIK is 0001092601
Past Insider Trading and Trends
2019 was Spa Essetifin's most active year for acquiring shares with 6 total transactions. Spa Essetifin's most active month to acquire stocks was the month of December. 2007 was Spa Essetifin's most active year for disposing of shares, totalling 1 transactions. Spa Essetifin's most active month to dispose stocks was the month of February. 2020 saw Spa Essetifin paying a total of $4,800,000.00 for 1,603,189 shares, this is the most they've acquired in one year. In 2018 Spa Essetifin cashed out on 3,133,681 shares for a total of $150,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FENNEC PHARMACEUTICALS INC. (FENC) Snapshot price: $5.29
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +23.81% | 768K |
$6.25 | $4,800,000.00 | 3.99M |
Apr 30
| |||
Form 4
| +10.03% | 294.12K |
$8.50 | $2,499,977.50 | 3.23M |
Dec 12
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DOR BIOPHARMA INC (SNGX) Snapshot price: $3.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$2.12 |
—
| 293.51K |
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
| +18.87% | 8.61M |
$0.21 | $1,764,758.90 | 54.23M |
Jun 18
| |||
Form 4
| +9.49% | 3.95M |
$0.25 | $999,999.96 | 45.62M |
Sep 24
| |||
Form 4
| +150.00% | 25M |
$0.18 | $4,500,000.00 | 41.67M |
Feb 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SCICLONE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.58M |
$5.25 | -$34,549,924.50 |
0
|
Apr 30
| |||
Form 4
| +0.44% | 28.6K |
$2.05 | $58,604.26 | 6.58M |
Jan 30
| |||
Form 4
| +0.01% | 400 |
$2.05 | $820.00 | 6.55M |
Jan 28
| |||
Form 4
| +0.56% | 36.29K |
$2.05 | $74,224.71 | 6.55M |
Jan 24 - Jan 25
| |||
Form 4
| +0.45% | 29.13K |
$2.01 | $58,629.86 | 6.52M |
Jan 22 - Jan 23
| |||
Form 4/A
| +0.00% | 200 |
$2.00 | $400.00 | 6.42M |
Jan 14
| |||
Form 4
| +0.99% | 63.33K |
$2.01 | $127,553.06 | 6.49M |
Jan 15 - Jan 16
| |||
Form 4
| +0.44% | 28.4K |
$2.00 | $56,782.40 | 6.42M |
Jan 11 - Jan 14
| |||
Form 4
| +0.86% | 54.64K |
$2.04 | $111,574.88 | 6.39M |
Nov 13
| |||
Form 4
| +0.27% | 17.36K |
$2.05 | $35,548.48 | 6.34M |
Nov 7 - Nov 8
| |||
Form 4
| +0.64% | 40.26K |
$2.05 | $82,361.73 | 6.32M |
Nov 5
| |||
Form 4
| +0.87% | 54.12K |
$2.05 | $110,885.71 | 6.28M |
Nov 1 - Nov 2
| |||
Form 4
| +0.40% | 25K |
$2.05 | $51,250.00 | 6.23M |
Oct 19
| |||
Form 4
| +0.67% | 41.27K |
$2.05 | $84,598.95 | 6.2M |
Oct 17 - Oct 18
| |||
Form 4
| +1.15% | 70K |
$2.06 | $143,950.00 | 6.16M |
Oct 15 - Oct 16
| |||
Form 4
| +0.40% | 24.34K |
$1.95 | $47,388.97 | 6.09M |
Oct 1 - Oct 2
| |||
Form 4
| +0.08% | 5K |
$5.00 | $25,000.00 | 6.07M |
Dec 16
| |||
Form 4
| +14.44% | 1.37M |
$4.90 | $6,825,181.79 | 10.86M |
Jun 17
| |||
Form 4/A
| +1.60% | 73.52K |
$4.52 | $332,514.79 | 4.67M |
Jun 15 - Jun 16
| |||
Form 4
| +1.60% | 73.52K |
$4.52 | $332,514.79 | 4.67M |
Jun 15 - Jun 16
| |||
Form 4
| +3.41% | 151.6K |
$4.19 | $634,950.00 | 4.59M |
Jun 10 - Jun 13
| |||
Form 4
| +15.99% | 612K |
$2.50 | $1,530,000.00 | 4.44M |
Jun 6 - Jun 7
| |||
Form 4
| +0.18% | 6.9K |
$2.58 | $17,787.51 | 3.83M |
Jun 1
| |||
Form 4
| +2.69% | 100K |
$2.43 | $243,180.00 | 3.82M |
May 26
| |||
Form 4
| +4.20% | 150K |
$2.38 | $357,170.00 | 3.72M |
May 24 - May 25
| |||
Form 4
| +0.96% | 33.8K |
$5.00 | $169,000.00 | 3.57M |
May 6
| |||
Form 4
| +0.01% | 481 |
$2.70 | $1,298.70 | 3.54M |
Apr 18
| |||
Form 4
| +0.84% | 29.5K |
$2.79 | $82,177.40 | 3.54M |
Apr 14 - Apr 15
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +0.01% | 500 |
$5.00 | $2,500.00 | 3.51M |
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
QUESTCOR PHARMACEUTICALS INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$4.68 |
—
| 7.25M |
Nov 20
| |||
Form 4
|
—
|
0
|
$1.50 |
—
| 9.5M |
Dec 20
| |||
Form 4
| +39.28% | 690K |
$1.45 | $1,000,500.00 | 2.45M |
Dec 13
| |||
Form 4
| -100.00% | -1.27M |
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
∞
| 100K |
$0.65 | $65,000.00 | 100K |
Apr 13
| |||
Form 4
| +22.27% | 100K |
$0.71 | $71,380.00 | 549.1K |
Apr 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
∞
| 759.49K |
$0.64 | $489,113.49 | 759.49K |
Jan 12
| |||
Form 4
| -0.06% | -10.00K |
$0.84 | -$8,409.00 | 16.43M |
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REGENERX BIOPHARMACEUTICALS INC (RGRXD) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
| +9.84% | 3.13M |
$0.06 | $188,020.86 | 34.99M |
Sep 27
| |||
Form 4
| +128.82% | 17.93M |
$0.23 | $4,124,744.79 | 31.86M |
Mar 13
| |||
Form 4
| +7.71% | 925.93K |
$0.27 | $250,000.02 | 12.94M |
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +7.46% | 833.33K |
$1.80 | $1,499,999.40 | 12.01M |
Dec 21
| |||
Form 4
| +2.41% | 263.16K |
$1.50 | $394,737.00 | 11.18M |
Jul 14
| |||
Form 4
| +7.19% | 731.85K |
$2.81 | $2,056,498.50 | 10.91M |
Mar 6
| |||
Form 4
| +2.83% | 307.69K |
$3.25 | $999,999.00 | 11.17M |
Jun 22
| |||
Form 4/A
|
—
|
0
|
—
|
—
| 19.75M |
Jan 7
| |||
Form 4
| +9.97% | 984.62K |
$3.25 | $3,199,998.75 | 10.86M |
Jan 3
| |||
Form 4
| +16.28% | 1.38M |
$1.09 | $1,499,999.48 | 9.88M |
Sep 2 - Sep 3
| |||
Form 4
| +14.15% | 1.05M |
$0.95 | $999,999.45 | 8.49M |
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||